Marshall Wace’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Marshall Wace’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,963	Closed	-$302K	–	2643
2024 Q2	$302K	Buy	+1,963	New	+$295K	﹤0.01%	2153
2023 Q4	–	Sell	-2,997	Closed	-$439K	–	2296
2023 Q3	$439K	Buy	+2,997	New	+$457K	﹤0.01%	1760
2023 Q2	–	Sell	-4,900	Closed	-$760K	–	2609
2023 Q1	$760K	Sell	4,900 -4,500	-48%	-$707K	﹤0.01%	1933
2022 Q4	$1.45M	Buy	9,400 +6,300	+203%	+$929K	﹤0.01%	1909
2022 Q3	$410K	Buy	+3,100	New	+$435K	﹤0.01%	2810
2022 Q1	–	Sell	-359	Closed	-$59K	–	3535
2021 Q4	$59K	Sell	359 -2,474	-87%	-$400K	﹤0.01%	3525
2021 Q3	$470K	Buy	2,833 +480	+20%	+$82K	﹤0.01%	2418
2021 Q2	$406K	Buy	+2,353	New	+$389K	﹤0.01%	2225
2019 Q4	–	Sell	-2,353	Closed	-$291K	–	1806
2019 Q3	$291K	Buy	+2,353	New	+$313K	﹤0.01%	1213

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Marshall Wace's FBT Position: Q3 2024 in Review

Marshall Wace sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2024, closing a stake of 1,963 shares — an estimated $302K sold.

Marshall Wace first reported a position in FBT in Q3 2019 and held it in 9 quarters. The position peaked at $1.45M in Q4 2022. 257 funds tracked by Wall St. Rank hold FBT as of Q3 2024.

Marshall Wace reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2024 after selling out during the quarter.
Marshall Wace sold 1,963 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2024, an estimated $302K.
Marshall Wace first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2019 and held it in 9 quarters.
Marshall Wace's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.45M in Q4 2022.
257 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2024.

Based on Marshall Wace's 13F filing for Q3 2024, filed 14 Nov 2024.